David Weinstock joined Merck/MSD in January 2022 as the Vice President of Discovery Oncology and is based in Boston. In that role, he leads the global preclinical effort to develop novel agents for patients with cancer. Dr....
According to industry sources on Monday, the German-based multinational pharmaceutical company plans to build additional manufacturing facilities of intermediate materials for biopharma products overseas and is seeking a final candidate site. Merck will reportedly announce a group of finalists within the fir...
Amgen Inc. 32.15 Warner Chilcott LLC 34.91 Daiichi Sankyo Inc. 35.97 DePuySynthes Sales Inc. 36.50 American Medical Systems Inc. 38.28 ArjoHuntleigh, Inc. 38.80 The Spectranetics Corporation 40.61 Par Pharmaceutical, Inc. 50.67 Aesculap, Inc. 57.01 Optimer Pharmaceuticals Inc. 57.06 Ellman Internationa...
The difference between these two strains of mice is that mouse L chain genes are still functional in the Medarex HuMAb-Mouse; thus, these mice can produce chimeric mAbs. The Xeno-Mouse from Amgen has all the mouse L chain genes deleted, and B cells produce only human Abs. One of these...
S.S.M. has received consulting and advisory fees from 89bio, Akcea, Amgen, Astra Zeneca, Esperion, Kaneka, Novo Nordisk, Quest Diagnostics, Sanofi, Regeneron and REGENXBIO and funding from Amgen. M.P.T. has received funding from Apple, AstraZeneca and Boehringer Ingelheim, consulting fees ...
Whereas reversible compounds are often prioritised based primarily on their potency in the initial stages of hit development, covalent compounds cannot be treated in the same manner, as IC50 measurements at one time point are not necessarily a correct representation of compounds activity. It is ...
AmgenGenentech, Inc.MaxCyte, Inc.Vertex PharmaceuticalsNeon TherapeuticsFood and Drug Administration (FDA)CRISPR TherapeuticsCorvus Pharmaceuticals, Inc Mark Terry MORE ON THIS TOPIC FDA 2024 Ends With Greenlights for Merck’s PAH Drug in UK and BMS’ Opdivo Injection in US ...
So it brings me great pleasure that we can play everyone’s favourite cycling based lottery for the first time this year! Break Candidates As always, it is a pretty difficult task trying to pick potential riders who will make the break but I’ll try my best! Jurgen Roelandts. Movistar ...
He is on the advisory boards and a consultant for Abbvie Inc.; Allergan; Amgen Inc.; Celgene Corporation; Janssen Pharmaceuticals, Inc.; Miraca Laboratories; Pfizer Inc.; Seres Therapeutics; Takeda Pharmaceuticals U.S.A., Inc.; and UCB, Inc. Instructions There are no fees for participating...
Intrinsic apoptosis is controlled by the BCL-2 family of proteins but the complexity of intra-family interactions makes it challenging to predict cell fate via standard molecular biology techniques. We discuss BCL-2 family regulation and how to determine